{"id":3680,"date":"2022-04-19T08:32:58","date_gmt":"2022-04-19T08:32:58","guid":{"rendered":"https:\/\/aceoncology.org\/?p=3680"},"modified":"2022-04-19T08:33:00","modified_gmt":"2022-04-19T08:33:00","slug":"darolutamide-extends-survival-in-metastatic-hormone-sensitive-prostate","status":"publish","type":"post","link":"https:\/\/aceoncology.org\/zh-hans\/darolutamide-extends-survival-in-metastatic-hormone-sensitive-prostate\/","title":{"rendered":"\u4e09\u836f\u8054\u5408\u5ef6\u957f\u8f6c\u79fb\u6027\u6fc0\u7d20\u654f\u611f\u6027\u524d\u5217\u817a\u764c\u751f\u5b58"},"content":{"rendered":"\n<p>\u8fd1\u5e74\u6765\u8f6c\u79fb\u6027\u3001\u6fc0\u7d20\u654f\u611f\u6027\u524d\u5217\u817a\u764c\uff08mHSPC\uff09\u60a3\u8005\u7684\u6cbb\u7597\u9009\u62e9\u8d8a\u6765\u8d8a\u591a\u6837\u3002\u6807\u51c6\u5168\u8eab\u6cbb\u7597\u5305\u62ec\u96c4\u6fc0\u7d20\u5265\u593a\u6cbb\u7597\uff08ADT\uff09\u8054\u5408\u591a\u897f\u4ed6\u8d5b\u5316\u7597\u6216\u96c4\u6fc0\u7d20\u53d7\u4f53\u901a\u8def\u9776\u5411\u6cbb\u7597\uff08\u5982\u963f\u6bd4\u7279\u9f99\u3001\u6069\u624e\u5362\u80fa\u3001\u963f\u5e15\u4ed6\u80fa\uff09\u3002\u8fd9\u79cd\u7597\u6cd5\u662f\u57fa\u4e8e\u5728\u51e0\u9879III\u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u89c2\u5bdf\u5230\u7684\u751f\u5b58\u83b7\u76ca\u3002\u6700\u8fd1\uff0cADT\u3001\u591a\u897f\u4ed6\u8d5b\u548c\u963f\u6bd4\u7279\u9f99\u4e09\u836f\u8054\u5408\u6cbb\u7597\u8fdb\u4e00\u6b65\u5ef6\u957f\u4e86\u751f\u5b58\u671f\uff08<a href=\"https:\/\/www.annalsofoncology.org\/article\/S0923-7534(21)04403-3\/fulltext\">PEACE-1\u7814\u7a76<\/a>\uff09\u3002\u6709\u8da3\u7684\u662f\uff0c\u6839\u636e<a href=\"https:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa1903835?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%20%200pubmed\">ENZAMET\u7814\u7a76<\/a>\u9884\u5148\u89c4\u5b9a\u7684\u4e9a\u7ec4\u5206\u6790\uff0c\u6069\u624e\u5362\u80fa\u8054\u5408ADT\u8054\u5408\u591a\u897f\u4ed6\u8d5b\u6cbb\u7597\u7ec4\u5374\u672a\u89c2\u5bdf\u5230\u751f\u5b58\u671f\u5ef6\u957f\u3002\u4eca\u5e74\u7684ASCO-GU\u4f1a\u8bae\u53d1\u8868\u4e86\u5927\u578b\u3001\u968f\u673a\u3001III\u671f<a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2119115\">ARASENS\u7814\u7a76<\/a>\u7684\u7ed3\u679c\uff0c\u8be5\u7814\u7a76\u6bd4\u8f83\u4e86\u63a5\u53d7ADT\u8054\u5408\u591a\u897f\u4ed6\u8d5b\u8054\u5408\u6216\u4e0d\u8054\u5408\u5f3a\u6548\u96c4\u6fc0\u7d20\u53d7\u4f53\u6291\u5236\u5242\u8fbe\u7f57\u4ed6\u80fa\u7684\u60a3\u8005\u7684\u751f\u5b58\u671f\u3002\u8fd9\u4e9b\u6570\u636e\u540c\u65f6\u53d1\u8868\u5728<a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/nejmoa1903835\">\u300a\u65b0\u82f1\u683c\u5170\u533b\u5b66\u6742\u5fd7\u300b<\/a>\u4e0a\u3002<\/p>\n\n\n\n<p>\u5171\u67091306\u4f8b\u60a3\u8005\u968f\u673a\u63a5\u53d7\u8fbe\u7f57\u4ed6\u80fa\u6216\u5b89\u6170\u5242\u8054\u5408ADT\u548c\u591a\u897f\u4ed6\u8d5b\u6cbb\u7597\u3002\u5728\u8fdb\u884c\u4e3b\u8981\u5206\u6790\u65f6\uff0c\u4e24\u7ec4\u7684\u4e2d\u4f4d\u968f\u8bbf\u65f6\u95f4\u5747\u8d85\u8fc740\u4e2a\u6708\u3002\u4e0e\u591a\u897f\u4ed6\u8d5b\u8054\u5408ADT\u76f8\u6bd4\uff0c\u8fbe\u7f57\u4ed6\u80fa\u8054\u5408\u591a\u897f\u4ed6\u8d5b\u8054\u5408ADT\u4f7f\u6b7b\u4ea1\u98ce\u9669\u964d\u4f4e32.5%\uff08\u98ce\u9669\u6bd4[HR] 0.68\uff1bP &lt; 0.001\uff09\u3002\u8fbe\u7f57\u4ed6\u80fa\u7ec4\u548c\u5b89\u6170\u5242\u7ec4\u7684\u4e2d\u4f4d\u6cbb\u7597\u6301\u7eed\u65f6\u95f4\u5206\u522b\u4e3a41.0\u4e2a\u6708\u548c16.7\u4e2a\u6708\u3002\u8fbe\u7f57\u4ed6\u80fa\u7ec4\u672a\u8fbe\u5230\u4e2d\u4f4dOS\uff0c\u5b89\u6170\u5242\u7ec4\u7684\u4e2d\u4f4dOS\u4e3a48.9\u4e2a\u6708\u3002\u8fbe\u7f57\u4ed6\u80fa\u7ec4\u548c\u5b89\u6170\u5242\u7ec4\u76844\u5e74OS\u7387\u5206\u522b\u4e3a62.7%\u548c50.4%\u3002\u8fbe\u7f57\u4ed6\u80fa\u7684\u751f\u5b58\u83b7\u76ca\u5728\u5927\u591a\u6570\u4e9a\u7ec4\u4e2d\u8868\u73b0\u4e00\u81f4\u3002\u503c\u5f97\u6ce8\u610f\u7684\u662f\uff0c\u5c3d\u7ba1\u5b89\u6170\u5242\u7ec4\u4e2d\u8d85\u8fc775%\u7684\u60a3\u8005\u63a5\u53d7\u4e86\u4e00\u79cd\u6216\u591a\u79cd\u540e\u7eed\u5168\u8eab\u6297\u80bf\u7624\u6cbb\u7597\uff08\u4e3b\u8981\u662f\u4e0d\u540c\u7684\u96c4\u6fc0\u7d20\u53d7\u4f53\u6291\u5236\u5242\uff09\uff0c\u4f46\u4ecd\u89c2\u5bdf\u5230\u4e86\u663e\u8457\u7684OS\u83b7\u76ca\u3002\u9664\u751f\u5b58\u671f\u83b7\u5f97\u6539\u5584\u5916\uff0c\u8fbe\u7f57\u4ed6\u80fa\u8054\u5408\u6cbb\u7597\u8fd8\u663e\u8457\u6539\u5584\u4e86\u6b21\u8981\u7ec8\u70b9\uff0c\u5305\u62ec\u81f3\u53d1\u751f\u53bb\u52bf\u62b5\u6297\u6027\u75be\u75c5\u7684\u65f6\u95f4\u3001\u81f3\u75bc\u75db\u8fdb\u5c55\u65f6\u95f4\u3001\u65e0\u75c7\u72b6\u6027\u9aa8\u9abc\u4e8b\u4ef6\u751f\u5b58\u671f\uff08\u5373\u81f3\u9996\u6b21\u53d1\u751f\u75c7\u72b6\u6027\u9aa8\u9abc\u4e8b\u4ef6\u7684\u65f6\u95f4\uff09\u3002\u81f3\u5f00\u59cb\u540e\u7eed\u5168\u8eab\u6297\u80bf\u7624\u6cbb\u7597\u7684\u65f6\u95f4\u4e5f\u663e\u8457\u5ef6\u957f\u3002\u91cd\u8981\u7684\u662f\uff0c\u4e24\u7ec4\u4e4b\u95f4\u4efb\u4f55\u7ea7\u522b\u7684\u4e0d\u826f\u4e8b\u4ef6\uff08AE\uff09\u9891\u7387\u76f8\u4f3c\uff0c\u5305\u62ec3-5\u7ea7AE\u548c\u4e25\u91cdAE\u3002\u4e2d\u6027\u7c92\u7ec6\u80de\u51cf\u5c11\u75c7\u662f\u6700\u5e38\u89c1\u76843\u7ea7\u62164\u7ea7AE\uff08\u8fbe\u7f57\u4ed6\u80fa\u7ec4\u4e3a33.7%\uff0c\u5b89\u6170\u5242\u7ec4\u4e3a34.2%\uff09\u3002\u4e24\u7ec4\u4e4b\u95f4\uff0c\u96c4\u6fc0\u7d20\u53d7\u4f53\u901a\u8def\u6291\u5236\u5242\u6cbb\u7597\u7684\u7279\u522b\u5173\u6ce8\u4e0d\u826f\u4e8b\u4ef6\uff08\u5982\u75b2\u4e4f\u3001\u8dcc\u5012\u3001\u9aa8\u6298\u3001\u7cbe\u795e\u635f\u5bb3\u548c\u5fc3\u8840\u7ba1\u4e8b\u4ef6\uff09\u53d1\u751f\u7387\u76f8\u4f3c\u3002<\/p>\n\n\n\n<p>\u4f5c\u8005\u5f97\u51fa\u7ed3\u8bba\uff0c\u7814\u7a76\u7ed3\u679c\u652f\u6301\u8fbe\u7f57\u4ed6\u80fa\u8054\u5408ADT\u548c\u591a\u897f\u4ed6\u8d5b\u6cbb\u7597mHSPC\u60a3\u8005\uff0c\u4e14\u4e0ePEACE-1\u7814\u7a76\u7684\u7ed3\u679c\u4e00\u81f4\u3002\u5728\u8bc4\u4f30\u7814\u7a76\u7684\u4f18\u52bf\u548c\u52a3\u52bf\u65f6\uff0c\u4ed6\u4eec\u6307\u51fa\u8be5\u7814\u7a76\u7684\u5927\u6837\u672c\u91cf\u80fd\u591f\u8fdb\u884c\u5f3a\u6709\u529b\u7684\u7edf\u8ba1\u5206\u6790\u3002\u7136\u800c\uff0c\u7531\u4e8e\u7eb3\u5165\u7814\u7a76\u7684\u6240\u6709\u60a3\u8005\u7684ECOG\u4f53\u529b\u72b6\u51b5\u8bc4\u5206\u5747\u4e3a0-1\u5206\uff0c\u56e0\u6b64\u65e0\u6cd5\u9884\u6d4b\u8fbe\u7f57\u4ed6\u80fa\u65b9\u6848\u5bf9\u4f53\u80fd\u72b6\u6001\u8f83\u5dee\u60a3\u8005\u7684\u5f71\u54cd\u3002\u6b64\u5916\uff0c\u7531\u4e8e\u5927\u591a\u6570ARASENS\u7814\u7a76\u53d7\u8bd5\u8005\u5728\u8bca\u65ad\u65f6\u5b58\u5728\u9aa8\u8f6c\u79fb\u548c\/\u6216\u5185\u810f\u8f6c\u79fb\uff0c\u6545\u672c\u7814\u7a76\u672a\u9488\u5bf9mHSPC\u60a3\u8005\u63d0\u4f9b\u83b7\u76ca-\u98ce\u9669\u6307\u5bfc\uff1b\u4e5f\u672a\u5bf9\u9488\u5bf9\u8f6c\u79fb\u6027\u75be\u75c5\u4e9a\u7ec4\u4eba\u7fa4\u63d0\u4f9b\u9884\u540e\u66f4\u4f73\u7684\u6307\u5bfc\uff0c\u5982\u590d\u53d1\u6027\u8f6c\u79fb\u6027\u75be\u75c5\u6216\u4ec5\u6709\u6dcb\u5df4\u7ed3\u8f6c\u79fb\u3002<\/p>\n\n\n\n<p><strong>\u53c2\u8003\u6587\u732e<\/strong><br>Smith MR, et al. <em>New Engl J Med<\/em>. 2022;386:1132-42.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u8fd1\u5e74\u6765\u8f6c\u79fb\u6027\u3001\u6fc0\u7d20\u654f\u611f\u6027\u524d\u5217\u817a\u764c\uff08mHSPC\uff09\u60a3\u8005\u7684\u6cbb\u7597\u9009\u62e9\u8d8a\u6765\u8d8a\u591a\u6837\u3002\u6807\u51c6\u5168\u8eab\u6cbb\u7597\u5305\u62ec\u96c4\u6fc0\u7d20\u5265\u593a\u6cbb\u7597\uff08ADT [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":3650,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[88],"tags":[],"class_list":["post-3680","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-88"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>\u4e09\u836f\u8054\u5408\u5ef6\u957f\u8f6c\u79fb\u6027\u6fc0\u7d20\u654f\u611f\u6027\u524d\u5217\u817a\u764c\u751f\u5b58 - ACE Oncology<\/title>\n<meta name=\"description\" content=\"\u8fbe\u7f57\u4ed6\u80fa\u4e09\u836f\u8054\u5408\u5ef6\u957f\u8f6c\u79fb\u6027\u6fc0\u7d20\u654f\u611f\u6027\u524d\u5217\u817a\u764c\u751f\u5b58\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/aceoncology.org\/zh-hans\/darolutamide-extends-survival-in-metastatic-hormone-sensitive-prostate\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u4e09\u836f\u8054\u5408\u5ef6\u957f\u8f6c\u79fb\u6027\u6fc0\u7d20\u654f\u611f\u6027\u524d\u5217\u817a\u764c\u751f\u5b58 - ACE Oncology\" \/>\n<meta property=\"og:description\" content=\"\u8fbe\u7f57\u4ed6\u80fa\u4e09\u836f\u8054\u5408\u5ef6\u957f\u8f6c\u79fb\u6027\u6fc0\u7d20\u654f\u611f\u6027\u524d\u5217\u817a\u764c\u751f\u5b58\" \/>\n<meta property=\"og:url\" content=\"https:\/\/aceoncology.org\/zh-hans\/darolutamide-extends-survival-in-metastatic-hormone-sensitive-prostate\/\" \/>\n<meta property=\"og:site_name\" content=\"ACE Oncology\" \/>\n<meta property=\"article:published_time\" content=\"2022-04-19T08:32:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-04-19T08:33:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/04\/Blog-Picture-84.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2000\" \/>\n\t<meta property=\"og:image:height\" content=\"2000\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"ACE Demo\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ace_oncology\" \/>\n<meta name=\"twitter:site\" content=\"@ace_oncology\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"ACE Demo\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/darolutamide-extends-survival-in-metastatic-hormone-sensitive-prostate\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/darolutamide-extends-survival-in-metastatic-hormone-sensitive-prostate\/\"},\"author\":{\"name\":\"ACE Demo\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/person\/b551dd0a4b75a5b349e0a71560a8b3c0\"},\"headline\":\"\u4e09\u836f\u8054\u5408\u5ef6\u957f\u8f6c\u79fb\u6027\u6fc0\u7d20\u654f\u611f\u6027\u524d\u5217\u817a\u764c\u751f\u5b58\",\"datePublished\":\"2022-04-19T08:32:58+00:00\",\"dateModified\":\"2022-04-19T08:33:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/darolutamide-extends-survival-in-metastatic-hormone-sensitive-prostate\/\"},\"wordCount\":43,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/aceoncology.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/darolutamide-extends-survival-in-metastatic-hormone-sensitive-prostate\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/04\/Blog-Picture-84.jpg\",\"articleSection\":[\"\u6587\u7ae0\u7cbe\u534e\"],\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/aceoncology.org\/zh-hans\/darolutamide-extends-survival-in-metastatic-hormone-sensitive-prostate\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/darolutamide-extends-survival-in-metastatic-hormone-sensitive-prostate\/\",\"url\":\"https:\/\/aceoncology.org\/zh-hans\/darolutamide-extends-survival-in-metastatic-hormone-sensitive-prostate\/\",\"name\":\"\u4e09\u836f\u8054\u5408\u5ef6\u957f\u8f6c\u79fb\u6027\u6fc0\u7d20\u654f\u611f\u6027\u524d\u5217\u817a\u764c\u751f\u5b58 - ACE Oncology\",\"isPartOf\":{\"@id\":\"https:\/\/aceoncology.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/darolutamide-extends-survival-in-metastatic-hormone-sensitive-prostate\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/darolutamide-extends-survival-in-metastatic-hormone-sensitive-prostate\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/04\/Blog-Picture-84.jpg\",\"datePublished\":\"2022-04-19T08:32:58+00:00\",\"dateModified\":\"2022-04-19T08:33:00+00:00\",\"description\":\"\u8fbe\u7f57\u4ed6\u80fa\u4e09\u836f\u8054\u5408\u5ef6\u957f\u8f6c\u79fb\u6027\u6fc0\u7d20\u654f\u611f\u6027\u524d\u5217\u817a\u764c\u751f\u5b58\",\"breadcrumb\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/darolutamide-extends-survival-in-metastatic-hormone-sensitive-prostate\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/aceoncology.org\/zh-hans\/darolutamide-extends-survival-in-metastatic-hormone-sensitive-prostate\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/darolutamide-extends-survival-in-metastatic-hormone-sensitive-prostate\/#primaryimage\",\"url\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/04\/Blog-Picture-84.jpg\",\"contentUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/04\/Blog-Picture-84.jpg\",\"width\":2000,\"height\":2000},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/darolutamide-extends-survival-in-metastatic-hormone-sensitive-prostate\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"ACE Oncology\",\"item\":\"https:\/\/aceoncology.org\/zh-hans\/chinese-home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u4e09\u836f\u8054\u5408\u5ef6\u957f\u8f6c\u79fb\u6027\u6fc0\u7d20\u654f\u611f\u6027\u524d\u5217\u817a\u764c\u751f\u5b58\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/aceoncology.org\/#website\",\"url\":\"https:\/\/aceoncology.org\/\",\"name\":\"ACE Oncology\",\"description\":\"ACE Oncology is a global independent medical education resource that provides evidence-based, high-quality educational solutions for clinicians that treat patients with cancer.\",\"publisher\":{\"@id\":\"https:\/\/aceoncology.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/aceoncology.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/aceoncology.org\/#organization\",\"name\":\"ACE Oncology\",\"url\":\"https:\/\/aceoncology.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png\",\"contentUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png\",\"width\":156,\"height\":83,\"caption\":\"ACE Oncology\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/ace_oncology\",\"https:\/\/www.linkedin.com\/company\/aceoncology\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/person\/b551dd0a4b75a5b349e0a71560a8b3c0\",\"name\":\"ACE Demo\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5364d75bb683367c9b56b8d9914df888527c9d170b78bbc5ef94bb01125a2253?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5364d75bb683367c9b56b8d9914df888527c9d170b78bbc5ef94bb01125a2253?s=96&d=mm&r=g\",\"caption\":\"ACE Demo\"},\"url\":\"https:\/\/aceoncology.org\/zh-hans\/author\/demo\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u4e09\u836f\u8054\u5408\u5ef6\u957f\u8f6c\u79fb\u6027\u6fc0\u7d20\u654f\u611f\u6027\u524d\u5217\u817a\u764c\u751f\u5b58 - ACE Oncology","description":"\u8fbe\u7f57\u4ed6\u80fa\u4e09\u836f\u8054\u5408\u5ef6\u957f\u8f6c\u79fb\u6027\u6fc0\u7d20\u654f\u611f\u6027\u524d\u5217\u817a\u764c\u751f\u5b58","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/aceoncology.org\/zh-hans\/darolutamide-extends-survival-in-metastatic-hormone-sensitive-prostate\/","og_locale":"zh_CN","og_type":"article","og_title":"\u4e09\u836f\u8054\u5408\u5ef6\u957f\u8f6c\u79fb\u6027\u6fc0\u7d20\u654f\u611f\u6027\u524d\u5217\u817a\u764c\u751f\u5b58 - ACE Oncology","og_description":"\u8fbe\u7f57\u4ed6\u80fa\u4e09\u836f\u8054\u5408\u5ef6\u957f\u8f6c\u79fb\u6027\u6fc0\u7d20\u654f\u611f\u6027\u524d\u5217\u817a\u764c\u751f\u5b58","og_url":"https:\/\/aceoncology.org\/zh-hans\/darolutamide-extends-survival-in-metastatic-hormone-sensitive-prostate\/","og_site_name":"ACE Oncology","article_published_time":"2022-04-19T08:32:58+00:00","article_modified_time":"2022-04-19T08:33:00+00:00","og_image":[{"width":2000,"height":2000,"url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/04\/Blog-Picture-84.jpg","type":"image\/jpeg"}],"author":"ACE Demo","twitter_card":"summary_large_image","twitter_creator":"@ace_oncology","twitter_site":"@ace_oncology","twitter_misc":{"\u4f5c\u8005":"ACE Demo","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"1 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/aceoncology.org\/zh-hans\/darolutamide-extends-survival-in-metastatic-hormone-sensitive-prostate\/#article","isPartOf":{"@id":"https:\/\/aceoncology.org\/zh-hans\/darolutamide-extends-survival-in-metastatic-hormone-sensitive-prostate\/"},"author":{"name":"ACE Demo","@id":"https:\/\/aceoncology.org\/#\/schema\/person\/b551dd0a4b75a5b349e0a71560a8b3c0"},"headline":"\u4e09\u836f\u8054\u5408\u5ef6\u957f\u8f6c\u79fb\u6027\u6fc0\u7d20\u654f\u611f\u6027\u524d\u5217\u817a\u764c\u751f\u5b58","datePublished":"2022-04-19T08:32:58+00:00","dateModified":"2022-04-19T08:33:00+00:00","mainEntityOfPage":{"@id":"https:\/\/aceoncology.org\/zh-hans\/darolutamide-extends-survival-in-metastatic-hormone-sensitive-prostate\/"},"wordCount":43,"commentCount":0,"publisher":{"@id":"https:\/\/aceoncology.org\/#organization"},"image":{"@id":"https:\/\/aceoncology.org\/zh-hans\/darolutamide-extends-survival-in-metastatic-hormone-sensitive-prostate\/#primaryimage"},"thumbnailUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/04\/Blog-Picture-84.jpg","articleSection":["\u6587\u7ae0\u7cbe\u534e"],"inLanguage":"zh-Hans","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/aceoncology.org\/zh-hans\/darolutamide-extends-survival-in-metastatic-hormone-sensitive-prostate\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/aceoncology.org\/zh-hans\/darolutamide-extends-survival-in-metastatic-hormone-sensitive-prostate\/","url":"https:\/\/aceoncology.org\/zh-hans\/darolutamide-extends-survival-in-metastatic-hormone-sensitive-prostate\/","name":"\u4e09\u836f\u8054\u5408\u5ef6\u957f\u8f6c\u79fb\u6027\u6fc0\u7d20\u654f\u611f\u6027\u524d\u5217\u817a\u764c\u751f\u5b58 - ACE Oncology","isPartOf":{"@id":"https:\/\/aceoncology.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/aceoncology.org\/zh-hans\/darolutamide-extends-survival-in-metastatic-hormone-sensitive-prostate\/#primaryimage"},"image":{"@id":"https:\/\/aceoncology.org\/zh-hans\/darolutamide-extends-survival-in-metastatic-hormone-sensitive-prostate\/#primaryimage"},"thumbnailUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/04\/Blog-Picture-84.jpg","datePublished":"2022-04-19T08:32:58+00:00","dateModified":"2022-04-19T08:33:00+00:00","description":"\u8fbe\u7f57\u4ed6\u80fa\u4e09\u836f\u8054\u5408\u5ef6\u957f\u8f6c\u79fb\u6027\u6fc0\u7d20\u654f\u611f\u6027\u524d\u5217\u817a\u764c\u751f\u5b58","breadcrumb":{"@id":"https:\/\/aceoncology.org\/zh-hans\/darolutamide-extends-survival-in-metastatic-hormone-sensitive-prostate\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/aceoncology.org\/zh-hans\/darolutamide-extends-survival-in-metastatic-hormone-sensitive-prostate\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/zh-hans\/darolutamide-extends-survival-in-metastatic-hormone-sensitive-prostate\/#primaryimage","url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/04\/Blog-Picture-84.jpg","contentUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/04\/Blog-Picture-84.jpg","width":2000,"height":2000},{"@type":"BreadcrumbList","@id":"https:\/\/aceoncology.org\/zh-hans\/darolutamide-extends-survival-in-metastatic-hormone-sensitive-prostate\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"ACE Oncology","item":"https:\/\/aceoncology.org\/zh-hans\/chinese-home\/"},{"@type":"ListItem","position":2,"name":"\u4e09\u836f\u8054\u5408\u5ef6\u957f\u8f6c\u79fb\u6027\u6fc0\u7d20\u654f\u611f\u6027\u524d\u5217\u817a\u764c\u751f\u5b58"}]},{"@type":"WebSite","@id":"https:\/\/aceoncology.org\/#website","url":"https:\/\/aceoncology.org\/","name":"ACE Oncology","description":"ACE Oncology is a global independent medical education resource that provides evidence-based, high-quality educational solutions for clinicians that treat patients with cancer.","publisher":{"@id":"https:\/\/aceoncology.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/aceoncology.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/aceoncology.org\/#organization","name":"ACE Oncology","url":"https:\/\/aceoncology.org\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/","url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png","contentUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png","width":156,"height":83,"caption":"ACE Oncology"},"image":{"@id":"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/ace_oncology","https:\/\/www.linkedin.com\/company\/aceoncology"]},{"@type":"Person","@id":"https:\/\/aceoncology.org\/#\/schema\/person\/b551dd0a4b75a5b349e0a71560a8b3c0","name":"ACE Demo","image":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5364d75bb683367c9b56b8d9914df888527c9d170b78bbc5ef94bb01125a2253?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5364d75bb683367c9b56b8d9914df888527c9d170b78bbc5ef94bb01125a2253?s=96&d=mm&r=g","caption":"ACE Demo"},"url":"https:\/\/aceoncology.org\/zh-hans\/author\/demo\/"}]}},"_links":{"self":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts\/3680","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/comments?post=3680"}],"version-history":[{"count":1,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts\/3680\/revisions"}],"predecessor-version":[{"id":3681,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts\/3680\/revisions\/3681"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/media\/3650"}],"wp:attachment":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/media?parent=3680"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/categories?post=3680"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/tags?post=3680"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}